• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌肿瘤微环境的细胞景观。

Cellular landscape of tumour microenvironment in prostate cancer.

机构信息

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Immunology. 2023 Feb;168(2):199-202. doi: 10.1111/imm.13456. Epub 2022 Mar 1.

DOI:10.1111/imm.13456
PMID:35146758
Abstract

Prostate cancer is still a public health priority in men and the impact of this disease will be more pronounced with the ageing of the world's population. Clinical heterogeneity of prostate cancer is reflected in spatial and clonal genomic diversity. Accumulating evidence demonstrates that the malignant behaviour of cancer is not only attributed to cancer cells but also fundamentally affected by stromal activity and controlled by various mechanisms of the tumour microenvironment. Data on prostate cancer in this study was derived from seven GEO datasets and the TCGA database. We analyzed the tumour microenvironment of prostate cancer in terms of clinical process, T stage and Gleason score using EPIC and xCell algorithms. We also analyzed the common immune checkpoints. In this study, we confirmed remarkable tumour tissue remodelling in the development of prostate cancer and further demonstrated the importance of cancer-related fibroblasts in the biochemical recurrence and metastasis for patients with prostate cancer undergoing radical radiotherapy or prostatectomy. In addition, we found that NRP1, CD200, TNFSF18 and CD80 might be the potential targets for prostate cancer.

摘要

前列腺癌仍然是男性健康的一个公共卫生重点,随着世界人口的老龄化,这种疾病的影响将更加明显。前列腺癌的临床异质性反映在空间和克隆基因组多样性上。越来越多的证据表明,癌症的恶性行为不仅归因于癌细胞,而且还受到基质活性的根本影响,并受肿瘤微环境的各种机制控制。本研究中前列腺癌的数据来自 7 个 GEO 数据集和 TCGA 数据库。我们使用 EPIC 和 xCell 算法,根据临床过程、T 分期和 Gleason 评分分析前列腺癌的肿瘤微环境。我们还分析了常见的免疫检查点。在这项研究中,我们证实了在前列腺癌发展过程中显著的肿瘤组织重塑,并进一步证明了在接受根治性放疗或前列腺切除术的前列腺癌患者中,与癌症相关的成纤维细胞在生化复发和转移中的重要性。此外,我们发现 NRP1、CD200、TNFSF18 和 CD80 可能是前列腺癌的潜在靶点。

相似文献

1
Cellular landscape of tumour microenvironment in prostate cancer.前列腺癌肿瘤微环境的细胞景观。
Immunology. 2023 Feb;168(2):199-202. doi: 10.1111/imm.13456. Epub 2022 Mar 1.
2
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.前列腺特异性抗原水平、分期或 Gleason 评分:哪一项最适合预测根治性前列腺切除术后的结果,并且它是否因所测量的结果而异?来自共享平等访问区域癌症医院数据库的结果。
Int J Urol. 2015 Apr;22(4):362-6. doi: 10.1111/iju.12704. Epub 2015 Feb 24.
3
Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer.建立与前列腺癌进展相关的免疫相关基因预后指标,并为肿瘤免疫微环境提供新的见解。
Immunology. 2022 Jun;166(2):197-209. doi: 10.1111/imm.13466. Epub 2022 Mar 16.
4
Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.在预测格里森 7 前列腺癌临床相关生化复发方面,阳性病理切缘的存在或缺失优于任何其他与切缘相关的变量。
BJU Int. 2013 May;111(6):921-7. doi: 10.1111/j.1464-410X.2012.11665.x. Epub 2013 Jan 25.
5
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.前列腺特异性抗原(PSA)密度预测初始前列腺活检和前列腺切除术中 Gleason 评分升级的能力随着肿瘤分级的增加而降低,这是由于单位肿瘤体积的 PSA 分泌减少所致。
BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.
6
Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.低危前列腺癌患者符合前列腺癌国际主动监测标准行根治性前列腺切除术的病理和生化结局。
BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.
7
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.从前列腺穿刺活检的 Gleason 评分 7 级降为前列腺切除术的 Gleason 评分 6 级对生化复发和前列腺癌特异性死亡率的影响。
J Urol. 2017 Apr;197(4):1060-1067. doi: 10.1016/j.juro.2016.11.079. Epub 2016 Nov 12.
8
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.对于接受根治性前列腺切除术治疗的 Gleason 评分 7 级前列腺癌的日本男性,原发 Gleason 模式的预后意义。
Urol Oncol. 2013 Nov;31(8):1511-6. doi: 10.1016/j.urolonc.2012.05.001. Epub 2012 May 31.
9
[Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins].[ Gleason评分对手术切缘阳性的根治性前列腺切除术后无生化复发生存的影响]
Prog Urol. 2017 Jun-Jul;27(8-9):467-473. doi: 10.1016/j.purol.2017.05.003. Epub 2017 May 30.
10
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.局限性前列腺癌中肿瘤缺氧和血管生成的内在标志物与根治性治疗结果:两项随机放疗试验和一项手术队列研究的回顾性分析
Lancet Oncol. 2008 Apr;9(4):342-51. doi: 10.1016/S1470-2045(08)70076-7. Epub 2008 Mar 17.

引用本文的文献

1
Advancing Prostate Cancer Treatment: Innovations and Challenges in Immunotherapy.晚期前列腺癌治疗:免疫疗法的创新与挑战
Cancer Treat Res. 2025;129:267-291. doi: 10.1007/978-3-031-97242-3_12.
2
Bolstering CD8 T Cells' Antitumor Immunity: A Promising Strategy to Improve the Response to Advanced Prostate Cancer Treatment.增强CD8 T细胞的抗肿瘤免疫力:一种改善晚期前列腺癌治疗反应的有前景的策略。
Biology (Basel). 2025 May 14;14(5):544. doi: 10.3390/biology14050544.
3
MicroRNA-18b-5p Inhibits the Malignant Progression of Prostate Cancer Through Downregulating TRAF5.
微小RNA-18b-5p通过下调TRAF5抑制前列腺癌的恶性进展。
Int J Gen Med. 2025 Mar 31;18:1831-1843. doi: 10.2147/IJGM.S494962. eCollection 2025.
4
Exploring the positive association of blood lipid levels with prostate cancer risk and their relationship to pathological features in the Chinese population.探讨中国人群血脂水平与前列腺癌风险的正相关及其与病理特征的关系。
Medicine (Baltimore). 2025 Mar 21;104(12):e41762. doi: 10.1097/MD.0000000000041762.
5
Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy.重编程胃癌中的肿瘤相关巨噬细胞:增强免疫治疗的途径
Front Immunol. 2025 Mar 3;16:1558091. doi: 10.3389/fimmu.2025.1558091. eCollection 2025.
6
Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes.基于端粒维持相关基因开发肝细胞癌的预后及药物治疗疗效预测模型。
Front Oncol. 2025 Feb 14;15:1544173. doi: 10.3389/fonc.2025.1544173. eCollection 2025.
7
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics.探索代谢途径在三阴性乳腺癌免疫治疗中的作用:来自单细胞和空间转录组学的见解
Front Endocrinol (Lausanne). 2025 Jan 9;15:1528248. doi: 10.3389/fendo.2024.1528248. eCollection 2024.
8
Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.肥胖、饮食干预与微生物群改变在前列腺癌发生发展中的作用
Front Immunol. 2025 Jan 7;15:1448116. doi: 10.3389/fimmu.2024.1448116. eCollection 2024.
9
Unraveling Alzheimer's disease: insights from single-cell sequencing and spatial transcriptomic.解析阿尔茨海默病:来自单细胞测序和空间转录组学的见解
Front Neurol. 2024 Dec 17;15:1515981. doi: 10.3389/fneur.2024.1515981. eCollection 2024.
10
A pan-cancer analysis of the oncogenic role of N-acetyltransferase 8 like in human cancer.N-乙酰转移酶8样蛋白在人类癌症中的致癌作用的泛癌分析
Discov Oncol. 2024 Dec 18;15(1):792. doi: 10.1007/s12672-024-01605-w.